Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
Hospital Clinic Barcelona
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Clinic Barcelona (15)
2024
-
Evidence and choice: The BCLC vision for tailoring clinical decision-making
Journal of Hepatology
-
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU
Revista espanola de enfermedades digestivas, Vol. 116, Núm. 2, pp. 83-113
-
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU
Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 401-432
2022
-
Liver diseases: a sanitary and social challenge for Europe in the XXI Century. Results of EASL-Lancet Comission
Medicina Clinica
-
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
The Lancet, Vol. 399, Núm. 10319, pp. 61-116
-
What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association
JHEP Reports, Vol. 4, Núm. 12
2021
-
Corrigendum to “Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules” [J Hepatol (2019) 874–884] (Journal of Hepatology (2019) 70(5) (874–884), (S0168827819300157), (10.1016/j.jhep.2019.01.005))
Journal of Hepatology
-
Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice
European Journal of Radiology, Vol. 135
-
The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis
CardioVascular and Interventional Radiology, Vol. 44, Núm. 1, pp. 50-62
2020
-
A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL
Digestive and Liver Disease, Vol. 52, Núm. 8, pp. 857-861
-
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis
Liver International, Vol. 40, Núm. 6, pp. 1467-1476
2019
-
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
Journal of Hepatology, Vol. 70, Núm. 5, pp. 874-884
2017
-
Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases
Future Oncology, Vol. 13, Núm. 23, pp. 2065-2082
2011
-
Research reporting standards for radioembolization of hepatic malignancies
Journal of Vascular and Interventional Radiology, Vol. 22, Núm. 3, pp. 265-278
2009
-
Diagnóstico y tratamiento del carcinoma hepatocelular
Medicina Clinica, Vol. 132, Núm. 7, pp. 272-287